Our focus is to deliver an effective, patient-friendly therapy for erectile dysfunction to individuals who require alternatives to oral medication. Comphya is a Swiss medical device company, spun out of the Swiss Federal Technology Institute of Lausanne (EPFL), dedicated to advancing treatment for erectile dysfunction.
Based on neuromodulation principles to restore natural nerve function
CaverSTIM™ applies advanced neuromodulation technology to the delicate cavernous nerves responsible for erectile function. By delivering targeted stimulation during and after surgery, the system aims to help preserve nerve health and support recovery during the critical healing window following radical prostatectomy.
Comfortable, drug-free therapy for men unresponsive to oral medications
For men who do not respond to oral therapies, current options can be invasive or unsatisfying. CaverSTIM™ offers a new path — designed to fit within standard surgical procedures and provide discreet, ongoing support for nerve recovery and erectile function.
EPFL spin-off translating science into meaningful outcomes for men's health
Founded at one of Europe's leading centers for innovation, Comphya unites expertise in biomedical engineering, neuroprosthetics, and clinical research. Our multidisciplinary team is advancing scientific discovery into a therapy that may redefine post-surgical recovery for men worldwide.
Our mission is to improve men's well-being by addressing nerve-related erectile challenges with Comphya's innovative technology, CaverSTIM™. Through precision neuromodulation, we aim to support natural function recovery for men affected by prostate cancer and other urologic procedures, helping restore confidence, intimacy, and quality of life.
Founded as a spin-off from EPFL, Comphya brings together experts in medical device development, urology, and neuroengineering to pioneer new standards in post-surgical care. With a foundation in rigorous research and patient-focused innovation, we are driven to deliver meaningful change for men affected by erectile dysfunction worldwide.
A multidisciplinary team combining decades of experience in medical devices, clinical research, and biomedical engineering.
Chief Executive Officer
Pim is a seasoned MedTech executive with over two decades of global leadership experience across startups and multinationals, including Medtronic, Carefusion, BD and AMF Medical, a start-up which he co-led till its acquisition by Tandem Diabetes Care.
Chief Operating Officer, Co-Founder, and Board Member
Pharmacologist with 50+ publications and multiple patents in sexual medicine and cardiovascular biology; oversees the technology development, quality management, regulatory and clinical affairs.
Chief Technology Officer & Co-Founder
Mikael Sturny is a co-founder of Comphya and serves as its Chief Technology Officer and Quality Manager, leading our technology and quality efforts.
Clinical Affairs Lead
Fiona is the Clinical Affairs Lead at Comphya, overseeing the clinical development of the CaverSTIM™ system.
Board Member
Senior executive with 35+ years in medical devices and capital equipment, with leadership roles at Medtronic, GE Medical Systems and others, focusing on strategy, market access, and growth.
Chief Operating Officer, Co-Founder, and Board Member
Pharmacologist with 50+ publications and multiple patents in sexual medicine and cardiovascular biology; oversees the technology development, quality management, regulatory and clinical affairs.
Board Member & Co-Founder
Professor at EPFL and Director of the Laboratory of Hemodynamics and Cardiovascular Technology; inventor and founder across multiple successful medical device ventures.
Board Member
Senior investment professional with extensive experience in medical technology, capital markets, and strategic business development. Managing Director at Innomedical Technology AG.
Advisor
Strategic advisor with extensive experience in medical technology commercialization and business development.
We partner with clinicians, researchers, and sponsors who share our focus on meaningful outcomes.